Cargando…

The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations

Silence information regulator 1 (SIRT1), a member of the sirtuin family, targets histones and many non-histone proteins and participates in various physiological functions. The enzymatic activity of SIRT1 is decreased in patients with Parkinson’s disease (PD), which may reduce their ability to resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xuan, Feng, Ya, Wang, Xi-Xi, Truong, Daniel, Wu, Yun-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673849/ https://www.ncbi.nlm.nih.gov/pubmed/33269110 http://dx.doi.org/10.14336/AD.2020.0216

Ejemplares similares

The Critical Role of Sirt1 in Subarachnoid Hemorrhages: Mechanism and Therapeutic Considerations
por: Zhang, Zhonghua, et al.
Publicado: (2023)

Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor
por: Wang, Xi-Xi, et al.
Publicado: (2020)

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies
por: Zhang, Jun-Fang, et al.
Publicado: (2021)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease
por: Li, Xuan, et al.
Publicado: (2021)

The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies
por: Zhang, Jun-Fang, et al.
Publicado: (2018)

FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics
por: Liu, Yiqiu, et al.
Publicado: (2021)

Complications of Critical COVID-19: Diagnostic and Therapeutic Considerations for the Mechanically Ventilated Patient
por: Maslove, David M., et al.
Publicado: (2022)

Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease
por: Mu, Ming-Dao, et al.
Publicado: (2020)

Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
por: Pan-Montojo, Francisco, et al.
Publicado: (2014)

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)

SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
por: Qi, Wenxiu, et al.
Publicado: (2022)

Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson’s disease
por: Maszlag-Török, Rita, et al.
Publicado: (2021)

Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1
por: Gomes, Bruno Alexandre Quadros, et al.
Publicado: (2018)

Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
por: Ewaisha, Radwa, et al.
Publicado: (2023)

The therapeutic role of minocycline in Parkinson’s disease
por: Cankaya, Seyda, et al.
Publicado: (2019)

Diet in Parkinson's Disease: Critical Role for the Microbiome
por: Jackson, Aeja, et al.
Publicado: (2019)

Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
por: Li, Xuan, et al.
Publicado: (2018)

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
por: Pajares, Marta, et al.
Publicado: (2020)

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
por: Kitada, Munehiro, et al.
Publicado: (2013)

Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease
por: Wu, Yuncheng, et al.
Publicado: (2011)

Role and Possible Mechanisms of Sirt1 in Depression
por: Lu, Guofang, et al.
Publicado: (2018)

Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism
por: Cui, Zhifu, et al.
Publicado: (2022)

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations
por: Kesayan, Tigran, et al.
Publicado: (2015)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
por: Chen, Tian-Jiao, et al.
Publicado: (2020)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
por: Su, Hui-Chen, et al.
Publicado: (2023)

Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
por: Nielsen, Pernille Y. Ø., et al.
Publicado: (2023)

SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
por: Chao, Chih-Chang, et al.
Publicado: (2022)

Hydrogen Sulfide Inhibits Homocysteine-Induced Neuronal Senescence by Up-Regulation of SIRT1
por: Kang, Xuan, et al.
Publicado: (2020)

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations [Corrigendum]
Publicado: (2016)

Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
por: Zhang, Shuo, et al.
Publicado: (2020)

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease
por: Vadalà, Maria, et al.
Publicado: (2015)

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
por: Brahmachari, Saurav, et al.
Publicado: (2017)

Role of SIRT5 in the analgesic effectiveness of moxibustion at ST36 in mice with inflammatory pain
por: Zuo, Chuan-yi, et al.
Publicado: (2023)

SIRT1: A promising therapeutic target for chronic pain
por: Song, Fan‐He, et al.
Publicado: (2022)

SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Emerging Roles of SIRT1 in Alcoholic Liver Disease
por: Ren, Ruixue, et al.
Publicado: (2020)

Potential therapeutic role of SIRT1 in age- related hearing loss
por: Zhao, Tingting, et al.
Publicado: (2022)

Cooperative effects of SIRT1 and SIRT2 on APP acetylation
por: Li, Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pdbfp2vtlahplhrkk4lvj5pa1g